|
TNKS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.155500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.615400E-01 |
| Normal-vs-Stage2 |
1.342810E-01 |
| Normal-vs-Stage3 |
1.183630E-01 |
| Normal-vs-Stage4 |
6.432000E-01 |
| Stage1-vs-Stage2 |
2.726000E-01 |
| Stage1-vs-Stage3 |
2.371200E-01 |
| Stage1-vs-Stage4 |
9.043400E-01 |
| Stage2-vs-Stage3 |
9.770600E-01 |
| Stage2-vs-Stage4 |
5.941600E-01 |
| Stage3-vs-Stage4 |
6.161800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.520100E-02 |
| Normal-vs-AfricanAmerican |
2.640200E-01 |
| Normal-vs-Asian |
1.434970E-01 |
| Caucasian-vs-AfricanAmerican |
6.586600E-01 |
| Caucasian-vs-Asian |
2.458400E-01 |
| AfricanAmerican-vs-Asian |
2.597000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.634400E-01 |
| Normal-vs-Female |
9.046100E-04 |
| Male-vs-Female |
5.436700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.379600E-01 |
| Normal-vs-Extreme_Weight |
8.646000E-01 |
| Normal-vs-Obese |
5.181500E-03 |
| Normal-vs-Extreme_Obese |
7.911800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.066800E-01 |
| Normal_Weight-vs-Obese |
1.223230E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.879200E-01 |
| Extreme_Weight-vs-Obese |
6.024800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.971000E-01 |
| Obese-vs-Extreme_Obese |
4.135600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.367900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.280590E-03 |
| Normal-vs-Age(61-80Yrs) |
9.549800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.937600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.800800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.528300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.417500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.257520E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.231030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.134000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.082190E-01 |
| Normal-VS-Type2 PRCC |
9.244800E-01 |
| Normal-VS-KIRP CIMP |
2.131600E-02 |
| Normal-VS-Unclassified PRCC |
1.864210E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.593170E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.581800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.542100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.115800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.966070E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.509500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.041600E-01 |
| Normal-vs-N1 |
7.135700E-02 |
| Normal-vs-N2 |
1.650370E-01 |
| N0-vs-N1 |
5.551700E-02 |
| N0-vs-N2 |
6.875600E-03 |
| N1-vs-N2 |
5.833400E-01 |
|
|
